Physician profile
Devon A Fuller
NPI 1174355002
$955.70
in general payments reported to CMS, 2019-2025
23 companies · $936 in 2025
The $936 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $19.48 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $237.33 | 2025 | Ozempic, Wegovy |
| Mannkind Corporation | $57.95 | 2025 | |
| Exact Sciences Corporation | $51.64 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $51.00 | 2025 | Zepbound, Mounjaro, Jardiance |
| Alvogen INC | $49.45 | 2025 | Teriparatide |
| Astellas Pharma US INC | $48.98 | 2025 | Veozah |
| Dexcom, INC. | $44.01 | 2025 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $40.63 | 2025 | Inspire |
| Sequel Med Tech, LLC | $37.33 | 2025 | Twiist |
| Beta Bionics, INC. | $36.14 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Glaxosmithkline, LLC. | $34.32 | 2025 | Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $32.83 | 2025 | |
| Axsome Therapeutics, INC. | $26.88 | 2025 | Auvelity |
| Neurocrine Biosciences, INC. | $25.43 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.22 | 2025 | Jardiance |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $24.17 | 2025 | Isturisa |
| Teva Pharmaceuticals USA, INC. | $22.90 | 2025 | Austedo Xr |
| Corcept Therapeutics | $20.94 | 2025 | Korlym |
| Antares Pharma, INC. | $19.90 | 2025 | Xyosted |
| Bolton Medical INC | $19.48 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Insulet Corporation | $18.47 | 2025 | Omnipod |
| Alexion Pharmaceuticals, INC. | $18.07 | 2025 | Strensiq |
| Spinal Simplicity, LLC | $13.63 | 2025 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.